HOLLISTON, Mass., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) ...
Harvard Bioscience said that once fully implemented, the move will provide about $4 million in annual cost savings.
The MarketWatch News Department was not involved in the creation of this content. HOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the "Company" or ...
HOLLISTON, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard ...
Harvard Bioscience makes laboratory instruments and devices that support research in areas like drug discovery, therapy development, and preclinical testing. Its core products are used by universities ...
F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced last week that it would more than triple ...
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results